With the goal of enabling more efficient and optimal clinical research, reporting, and quality inside healthcare institutions, the company’s Synapsis AI platform automates the reading and analysis of medical data.
According to the business, large healthcare organisations will use its platform to automate complex registry reporting, conduct automated chart checks for observational studies, and discover enterprise-wide clinical trial pre-screening. In an email to MobiHealthNews, Dyania Health CEO and cofounder Eirini Schlosser stated, “The healthcare industry continues to struggle with inefficiencies in managing unstructured data and delays in clinical trial recruitment.
We can move more quickly towards our goal of using AI to revolutionise healthcare data management thanks to this support. We can solve significant inefficiencies in patient care and clinical research by enhancing our AI skills. Our Synapsis AI technology, which is currently transforming the speed and precision of medical data analysis, will be able to grow with the new financing. We will keep expanding our technology with this help in order to satisfy the rising demands of life sciences firms and healthcare systems.
Also Read:
India Becomes the fourth Nation to Surpass $700 Billion in Foreign Exchange ReservesProgram
Deepinder Goyal of Zomato is leaving Shark Tank India, and Rival Swiggy will be Sponsoring the
